Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vortioxetine versus other antidepressants in the treatment of burning mouth syndrome: An open‐label randomized trial
Daniela Adamo, Giuseppe Pecoraro, Noemi Coppola, et al.
Oral Diseases (2020) Vol. 27, Iss. 4, pp. 1022-1041
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Burning mouth syndrome: Analysis of diagnostic delay in 500 patients
Daniela Adamo, Elena Calabria, Federica Canfora, et al.
Oral Diseases (2023) Vol. 30, Iss. 3, pp. 1543-1554
Open Access | Times Cited: 16
Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review
Javier de Diego-Adeliño, José Manuel Crespo, Fernando A. Lázaro Mora, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 5, pp. 673-690
Open Access | Times Cited: 40
Burning Mouth Syndrome: An Overview and Future Perspectives
Daniela Adamo, Gianrico Spagnuolo
International Journal of Environmental Research and Public Health (2022) Vol. 20, Iss. 1, pp. 682-682
Open Access | Times Cited: 24
Analysis of Duloxetine-Related Adverse Events Using the Food and Drug Administration Adverse Event Reporting System
Meng Zhu, Feiye Zhu, Yongsheng Zhang
Journal of Clinical Psychopharmacology (2025)
Closed Access
Chronic orofacial pain and pharmacological management – a Clinical guide
Guangzhao Guan, A Polonowita, Li Mei, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2025)
Open Access
Short‐Term Dietary Caffeine Intake for Alleviating Symptoms of Burning Mouth Syndrome: A Randomised Controlled Comparison With Alpha‐Lipoic Acid
Chuanji Wu, Peiyang Yuan, Xuemei Qiu, et al.
Journal of Oral Rehabilitation (2025)
Closed Access
Obsessive-compulsive symptoms and traits in patients with burning mouth syndrome: a cross-sectional multicentric analysis
Luca Pellegrini, Federica Canfora, Giulia Ottaviani, et al.
Clinical Oral Investigations (2025) Vol. 29, Iss. 4
Open Access
Burning Fog: Cognitive Impairment in Burning Mouth Syndrome
Federica Canfora, Elena Calabria, Renato Cuocolo, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 23
The antidepressant drugs vortioxetine and duloxetine differentially and sex-dependently affect animal well-being, cognitive performance, cardiac redox status and histology in a model of osteoarthritis
Katarina Nastić, Uroš Pecikoza, Milica Labudović‐Borović, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115360-115360
Open Access | Times Cited: 8
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Daniela Adamo, Elena Calabria, Noemi Coppola, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 18
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder Associated with Chronic Pain: An Observational Study in a Spanish Population
Jordi Folch Ibáñez, Maribel Vargas Domingo, Joan Coma Alemany, et al.
Pain and Therapy (2024) Vol. 13, Iss. 3, pp. 621-635
Open Access | Times Cited: 2
Vortioxetine as an alternative treatment for somatic symptom disorder: case report
Naoki Furutani, Yasuhide Nagoshi
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Serotonergic Neurotransmission System Modulator, Vortioxetine, and Dopaminergic D2/D3 Receptor Agonist, Ropinirole, Attenuate Fibromyalgia-Like Symptoms in Mice
Kinga Sałat, Anna Furgała
Molecules (2021) Vol. 26, Iss. 8, pp. 2398-2398
Open Access | Times Cited: 15
Vortioxetine treatment for neuropathic pain in major depressive disorder: a three-month prospective study
Sinan Eliaçık, Ayşe Erdoğan Kaya
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
The Role of Vortioxetine in the Treatment of Depressive Symptoms in General Hospital Psychiatry: A Case-Series and PRISMA-Compliant Systematic Review of the Literature
Francesco Weiss, Bruno Pacciardi, Giulia D’Alessandro, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 531-531
Open Access | Times Cited: 1
Vortioxetine reduces the development of pain‐related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down‐regulation
Maja Tomić, Katarina Nastić, Miroslav Dinić, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 24, pp. 5079-5093
Open Access | Times Cited: 1
Blueprint Persona and ICT Interventions: Addressing Unmet Needs in Burning Mouth Syndrome Care
Federica Canfora, Christine Mauro, Mignogna Michele Davide, et al.
Journal of Evidence Based Dental Practice (2024), pp. 102047-102047
Open Access | Times Cited: 1
Occlusal tactile acuity in patients with burning mouth syndrome: A case-control study
Federica Canfora, Daniela Adamo, Roberto Rongo, et al.
Seminars in Orthodontics (2023) Vol. 30, Iss. 3, pp. 329-334
Open Access | Times Cited: 3
Role of vortioxetine in the treatment of neuropathic pain
A. Alcántara Montero, S.R. Pacheco de Vasconcelos
Revista Española de Anestesiología y Reanimación (English Edition) (2022) Vol. 69, Iss. 10, pp. 640-648
Closed Access | Times Cited: 5
Papel de vortioxetina en el tratamiento del dolor neuropático
A. Alcántara Montero, S.R. Pacheco de Vasconcelos
Revista Española de Anestesiología y Reanimación (2021) Vol. 69, Iss. 10, pp. 640-648
Closed Access | Times Cited: 4
An overview of the safety and efficacy of LX-9211 in treating neuropathic pain conditions
William C. Upshaw, John M. Richey, Gurjot Ravi, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 8, pp. 829-837
Closed Access
Burning mouth syndrome: a literary review and an uptade
M Mazzuka
Annali di stomatologia (2023) Vol. 12, Iss. 1-4, pp. 2-2
Open Access | Times Cited: 1
Efficacy of Danzhixiaoyao pills in the treatment of burning mouth syndrome：An randomized controlled trial
Ya Gao, Jing‐Wen Yang, Huimin Sun, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Management of burning mouth syndrome
Hanna Hüpsch-Marzec, Paweł Cieślik, Agnieszka Gorzkowska
Aktualności Neurologiczne (2023) Vol. 23, Iss. 2, pp. 36-40
Open Access
Mechanisms of action and clinical effects of vortioxetine
Н. Н. Петрова, A A Mukhin
S S Korsakov Journal of Neurology and Psychiatry (2022) Vol. 122, Iss. 6, pp. 84-84
Closed Access
Page 1 - Next Page

Scroll to top